2007•GastroenterologyOpen access

Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B

Robert G. Gish, Anna S. Lok, Ting‐Tsung Chang, Robert Auke de Man, Adrian Carlos Gadano, Jose Decena Sollano, Kwang‐Hyub Han, You‐Chen Chao, Shou–Dong Lee, Melissa Nauta Harris, Chaoho Ouyang, Richard J. Colonno, Helena Brett‐Smith

Open full text 369 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 369 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Entecavir, Chronic hepatitis, Medicine, Gastroenterology, Internal medicine, HBeAg, Virology, Hepatitis a virus

Back to paper search Browse research topics Original source

Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B — Research Paper | ScholarLens